<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Endocrinol</journal-id><journal-id journal-id-type="publisher-id">IJE</journal-id><journal-title-group><journal-title>International Journal of Endocrinology</journal-title></journal-title-group><issn pub-type="ppub">1687-8337</issn><issn pub-type="epub">1687-8345</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4020466</article-id><article-id pub-id-type="doi">10.1155/2014/302602</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2899-6762</contrib-id><name><surname>Hirata</surname><given-names>Takumi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6988-6338</contrib-id><name><surname>Tomita</surname><given-names>Kengo</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4419-337X</contrib-id><name><surname>Kawai</surname><given-names>Toshihide</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Yokoyama</surname><given-names>Hirokazu</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shimada</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kikuchi</surname><given-names>Masahiro</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hirose</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ebinuma</surname><given-names>Hirotoshi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Irie</surname><given-names>Junichiro</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ojiro</surname><given-names>Keisuke</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Oikawa</surname><given-names>Yoichi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4812-8498</contrib-id><name><surname>Saito</surname><given-names>Hidetsugu</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Itoh</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hibi</surname><given-names>Toshifumi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan</aff><aff id="I2"><sup>2</sup>Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa-Shi, Saitama 359-8513, Japan</aff><author-notes><corresp id="cor1">*Toshihide Kawai: <email>tkawai@a3.keio.jp</email></corresp></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>27</day><month>4</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>302602</elocation-id><history><date date-type="received"><day>5</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014 Takumi Hirata et al.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article id="d35e250" related-article-type="corrected-article" xlink:href="23997767" ext-link-type="pubmed" vol="2013">1-9</related-article></article-meta></front><body><p><offsets xml_i="5371" xml_f="5618" txt_i="7" txt_f="254">
In the paper, the dosage of telmisartan is incorrect due to a typographical error. Twelve patients, assigned to telmisartan group, received telmisartan at a dose of 40 mg, not 20 mg, once a day. The correct sentences should appear as given below.</offsets><list list-type="order"><list-item><p><offsets xml_i="5656" xml_f="5792" txt_i="254" txt_f="390">“Nineteen hypertensive NAFLD patients with type 2 diabetes were randomly assigned to receive telmisartan at a dose of 40 mg once a day (</offsets><italic><offsets xml_i="5800" xml_f="5801" txt_i="390" txt_f="391">n</offsets></italic><offsets xml_i="5810" xml_f="5860" txt_i="391" txt_f="441"> = 12) or losartan at a dose of 50 mg once a day (</offsets><italic><offsets xml_i="5868" xml_f="5869" txt_i="441" txt_f="442">n</offsets></italic><offsets xml_i="5878" xml_f="5942" txt_i="442" txt_f="506"> = 7) for 12 months” in the “Methods” section of the “Abstract.”</offsets></p></list-item><list-item><p><offsets xml_i="5972" xml_f="6131" txt_i="507" txt_f="666">“Nineteen hypertensive NAFLD patients with type 2 diabetes were randomly assigned to the telmisartan (T) group (receiving a standard dose of 40 mg once daily, </offsets><italic><offsets xml_i="6139" xml_f="6140" txt_i="666" txt_f="667">n</offsets></italic><offsets xml_i="6149" xml_f="6230" txt_i="667" txt_f="748"> = 12) or the losartan (L) group (receiving a standard dose of 50 mg once daily, </offsets><italic><offsets xml_i="6238" xml_f="6239" txt_i="748" txt_f="749">n</offsets></italic><offsets xml_i="6248" xml_f="6270" txt_i="749" txt_f="771"> = 7)” in Section 2.2.</offsets></p></list-item></list><offsets xml_i="6293" xml_f="6294" txt_i="772" txt_f="773">
</offsets></p></body></article>